Significant Gains in Rheumatoid Arthritis Quality Measures Among RISE Registry Practices.

Significant Gains in Rheumatoid Arthritis Quality Measures Among RISE Registry Practices.
复制标题

DOI:
10.1002/acr.24444
复制
发表时间:
2022-03
影响因子:
4.7
通讯作者:
Yazdany J
Yazdany J
中科院分区:
医学2区
文献类型:
--
作者:
Izadi Z;Schmajuk G;Gianfrancesco M;Subash M;Evans M;Trupin L;Yazdany J

文献摘要

参考文献

被引文献

相似文献

Using the American College of Rheumatology’s RISE registry, we examined performance on rheumatoid arthritis (RA) quality measures and assessed the association between practice characteristics and changes in performance over time among participating practices. We analyzed data from practices enrolled in RISE between January 1, 2015 and December 31, 2017. Eight quality measures in the areas of RA disease management, cardiovascular risk reduction, and patient safety were examined. Variability in performance was evaluated at the practice level. Multivariate linear models were used to predict change in measure performance by year and determine the effect of practice characteristics on change in performance over time. Data from 59,986 patients from 54 practices was examined. Mean age was 62±14 years, 77% were female, 69% were Caucasian, and most patients were seen in a single-specialty group practice (46%). Average performance on measures related to RA treatments was consistently high (>90%) across the study period. Measures related to RA functional status and disease activity assessment had the greatest improvements over time (8.4% and 13.0% increase per year, respectively; p<0.001). Single-specialty group practices had the fastest rates of improvement over time across all measures. Among practices participating in RISE between 2015 to 2017, performance on most RA quality measures improved. Single specialty group practices saw the fastest rates of improvement over time. Identification of workflow patterns leading to dramatic improvements in quality of care will help guide process redesign to address gaps in priority areas, such as TB screening and blood pressure control.
DOI: 10.1002/acr.23612
发表时间: 2019-04
影响因子: 4.7
作者:
Bartels CM;Ramly E;Johnson HM;Lauver DR;Panyard DJ;Li Z;Sampene E;Lewicki K;McBride PE
通讯作者: McBride PE
DOI: 10.1001/jama.2011.67
发表时间: 2011-02-02
影响因子: 120.7
作者:
Schmajuk, Gabriela;Trivedi, Amal N.;Yazdany, Jinoos
通讯作者: Yazdany, Jinoos
DOI: 10.1002/acr.23089
发表时间: 2016-12-01
影响因子: 4.7
作者:
Yazdany, Jinoos;Bansback, Nick;Kazi, Salahuddin
通讯作者: Kazi, Salahuddin
DOI: 10.1001/jama.2013.108769
发表时间: 2013-08-21
影响因子: 120.7
作者:
Jaffe, Marc G.;Lee, Grace A.;Young, Joseph D.;Sidney, Stephen;Go, Alan S.
通讯作者: Go, Alan S.
DOI: 10.1002/pds.1231
发表时间: 2006-10-01
影响因子: 2.6
作者:
Sturmer, Til;Rothman, Kenneth J.;Glynn, Robert J.
通讯作者: Glynn, Robert J.